September 2026
M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement

Jorge Alberto Barragán/LinkedIn

Aug 3, 2026, 12:14

Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement

Yaqui Valenzuela, Medical Science Liaison at Pfizer, shared Jorge Alberto Barragán’s post on LinkedIn:

“Hemophilia is a little-known disease with few treatments that allow patients to lead a good quality of life.

What lies ahead will undoubtedly change the paradigm of this condition—not only improving the patients’ quality of life, but also helping us start to make women visible within it.

We have a great challenge ahead, but I have no doubt that we will also pave the way.

Congratulations!”

Jorge Alberto Barragán, Medical Lead of Specialty Care and Internal Medicine at Pfizer, shared a post on LinkedIn:

“Innovation in hemophilia continues to evolve to address unmet needs that remain in clinical practice.

Beyond the remarkable advances achieved with factor replacement therapies, new therapeutic approaches are expanding treatment possibilities, aiming to reduce treatment burden, improve patient experience, and support more individualized care.

Continued investment in research and access to innovation will be essential to further improve outcomes for people living with hemophilia in Mexico.

Thanks to our speakers: Aída Mashenka Moreno Gonzalez, Akshat Jain, Jimenez Yuste, Ana Laura Alvarez, Garcia Chavez.

Thank you for this great event.”

Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement